首页> 外国专利> CONSTRUCTION AND CRYSTALLIZATION OF EXPRESSION SYSTEM FOR RNA POLYMERASE PB1-PB2 PROTEIN DERIVED FROM INFLUENZA VIRUS

CONSTRUCTION AND CRYSTALLIZATION OF EXPRESSION SYSTEM FOR RNA POLYMERASE PB1-PB2 PROTEIN DERIVED FROM INFLUENZA VIRUS

机译:流感病毒RNA聚合酶PB1-PB2蛋白表达系统的构建与结晶

摘要

The present invention aims to express influenza virus RNA polymerase on a large scale, to crystallize the influenza virus RNA polymerase, and to provide a method for screening a substance capable of serving as an active ingredient in anti-influenza drugs. The present invention provides a complex comprising a polypeptide consisting of an amino acid sequence at positions 678-757 of the RNA polymerase PB1 subunit in influenza A/Puerto Rico/8/34 H1N1 and a polypeptide consisting of an amino acid sequence at positions 1-37 of RNA polymerase PB2 subunit in influenza A/Puerto Rico/8/34 H1N1. This complex can be crystallized in the presence of a precipitant such as potassium phosphate and PEG4000. Moreover, with the use of information on the crystal structure of this complex, it is possible to provide a method for screening a substance capable of serving as an active ingredient in anti-influenza drugs.
机译:本发明的目的是大规模表达流感病毒RNA聚合酶,使流感病毒RNA聚合酶结晶,并提供一种筛选能够用作抗流感药物活性成分的物质的方法。本发明提供了一种复合物,其包含由A型流感/波多黎各/ 8/34 H1N1流感病毒的RNA聚合酶PB1亚基的678-757位氨基酸序列组成的多肽和由1位氨基酸序列组成的多肽甲型/波多黎各/ 8/34 H1N1型流感病毒中RNA聚合酶PB2亚基的37个。该复合物可以在沉淀剂如磷酸钾和PEG4000的存在下结晶。此外,利用关于该络合物的晶体结构的信息,可以提供一种筛选能够用作抗流感药物中的活性成分的物质的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号